DK3071196T3 - HDAC-inhibitorer til undertrykkelse af cancerforbundet kakeksi - Google Patents

HDAC-inhibitorer til undertrykkelse af cancerforbundet kakeksi Download PDF

Info

Publication number
DK3071196T3
DK3071196T3 DK14824959.2T DK14824959T DK3071196T3 DK 3071196 T3 DK3071196 T3 DK 3071196T3 DK 14824959 T DK14824959 T DK 14824959T DK 3071196 T3 DK3071196 T3 DK 3071196T3
Authority
DK
Denmark
Prior art keywords
suppression
cancer
hdac inhibitors
associated cachexia
cachexia
Prior art date
Application number
DK14824959.2T
Other languages
English (en)
Inventor
Ching-Shih Chen
Tanios Bekaii-Saab
Denis Guttridge
Samuel Kulp
Yu-Chou Tseng
Guido Marcucci
Original Assignee
Ohio State Innovation Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State Innovation Foundation filed Critical Ohio State Innovation Foundation
Priority claimed from PCT/US2014/066435 external-priority patent/WO2015077353A1/en
Application granted granted Critical
Publication of DK3071196T3 publication Critical patent/DK3071196T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14824959.2T 2013-11-20 2014-11-19 HDAC-inhibitorer til undertrykkelse af cancerforbundet kakeksi DK3071196T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361906738P 2013-11-20 2013-11-20
PCT/US2014/066435 WO2015077353A1 (en) 2013-11-20 2014-11-19 Hdac inhibitors for suppressing cancer-related cachexia

Publications (1)

Publication Number Publication Date
DK3071196T3 true DK3071196T3 (da) 2019-07-01

Family

ID=56737824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14824959.2T DK3071196T3 (da) 2013-11-20 2014-11-19 HDAC-inhibitorer til undertrykkelse af cancerforbundet kakeksi

Country Status (4)

Country Link
EP (1) EP3071196B1 (da)
CN (1) CN106029061B (da)
DK (1) DK3071196T3 (da)
ES (1) ES2729619T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019055687A1 (en) * 2017-09-13 2019-03-21 Ohio State Innovation Foundation METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229237A1 (en) * 2005-04-07 2006-10-12 Yih-Lin Chung Treatment of gastrointestinal distress
GB0612273D0 (en) * 2006-06-21 2006-08-02 Friedrich Miescher Inst For Bi Prevention of muscle atrophy
MX2014006409A (es) * 2011-11-28 2014-07-30 Novartis Ag Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.

Also Published As

Publication number Publication date
ES2729619T3 (es) 2019-11-05
CN106029061B (zh) 2019-08-09
EP3071196A1 (en) 2016-09-28
EP3071196B1 (en) 2019-03-27
CN106029061A (zh) 2016-10-12

Similar Documents

Publication Publication Date Title
DK3371171T3 (da) Inhibitorer af RET
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3027618T3 (da) Polymorf af syk-hæmmere
DK3071698T3 (da) Excision og indsættelse af stort gen
DK3066085T3 (da) Fremgangsmåde til syntesen af en indolamin-2,3-dioxygenaseinhibitor
DK3022217T3 (da) Sammensætninger til modulering af tau-ekspression
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK3008039T3 (da) Krystallinsk form af en mdm2-inhibitor
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3068776T3 (da) Inhibitorer af replikation af influenzavira
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3054782T3 (da) Fremgangsmåde til tørring af biomasse
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3071670T3 (da) Integreret fremgangsmåde til fremstilling af carbonhydrider
DK3680000T3 (da) Fremgangsmåder til oprensning af antistoffer
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2985275T3 (da) Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre
EP3632467C0 (en) INHIBITORS OF COMPLEMENT FACTOR H
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK2948134T3 (da) Sammensætninger til transdermal indgivelse af mtor-inhibitorer